PRODUCTS

INTERNATIONAL  /  RISEDRONATE «  BACK TO "INTERNATIONAL"

Risedronate is a bisphosphonate which binds to bone hydroxyapatite and inhibits osteoclast-mediated bone resorption.

Risedronate is indicated for the treatment of postmenopausal osteoporosis and the reduction of the risk of vertebral fractures.

Active ingredient Pharmaceutical form Package Therapeutic target
  • Risedronate
  • F.c. Tablets
  • 5mg
  • 30mg
  • 35mg
  • Bone Metabolism-Osteoporosis

Other products in "International"